Neuroimaging and neurobiology of social anxiety;Neuroimaging e neurobiologia dell'ansia sociale

Rivista di Psichiatria

Volumn 45, Issue 6, 2010, Pages 349-360

  Pietrini, Francesco ^a   Godini, Lucia ^a   Lazzeretti, Lisa ^a   Benni, Laura ^a   Pracucci, Chiara ^a   Talamba, Gabriela Alina ^a   Faravelli, Carlo ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Functional neuroimaging; Neurobiology; Shyness; Social anxiety disorder; Social phobia; Structural neuroimaging

Indexed keywords

ADOLESCENT; ADULT; AMYGDALOID NUCLEUS; BRAIN REGION; EMOTION; FEAR; HIPPOCAMPUS; HUMAN; INSULA; NEUROBIOLOGY; NEUROIMAGING; PERCEPTION; PREFRONTAL CORTEX; PROCESSING; RESEARCH; REVIEW; SOCIAL PHOBIA;

ANXIETY DISORDERS; BRAIN; HUMANS; MAGNETIC RESONANCE IMAGING; PHOBIC DISORDERS; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; SOCIAL ENVIRONMENT;

EID: 78651409786     PISSN: 00356484     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (90)

1. Ruscio AM, Brown TA, Chiu WT, Sareen J, Stein MB, Kessler RC. Social fears and social phobia in the USA: results from the National Comorbidity Survey Replication. Psych Med 2008; 38: 15-28. (Pubitemid 350275216)
2. Pietrini F, Lelli L, Lo Sauro C, Faravelli C. Epidemiology of social phobia. Riv Psichiatr 2009; 44: 203-13.
3. Eaton WW, Dryman A, Weissman MM. Panic and phobia. In: Robins LN, Reiger DA (eds). Psychiatric disorders in America: the Epidemiological Catchment Area Study. New York: Free Press, 1991.
4. Wittchen HU, Stein MB, Kessler RC. Social fears and social phobia in a community sample of young adults: prevalence, risk factors, and comorbidity. Psych Med 1999; 29: 309-23.
5. Faravelli C, Zucchi T, Viviani B, Salmoria R, Perone A, Paionni A, et al. Epidemiology of social phobia: a clinical approach. Eur Psych 2000; 15: 17-24. (Pubitemid 30129486)
6. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorder, 4th edition text revision.Washington DC:American Psychiatric Association, 2000.
7. Stein MB, Stein DJ. Social anxiety disorder. Lancet 2008; 371: 1115-25.
8. Zimbardo PG, Pilkonis PA, Norwood RM. The social disease called shyness. Psychol Today 1975; 8: 68-72.
9. Rosenbaun JF, Beiderman J, Pollock RA, Hirsfeld DR. The etiology of social phobia. J Clin Psychiatry 1994; 55 (suppl 6): 10-6.
10. Trower P, Gilbert P. New theoretical conceptions of social phobia. Clin Psychol Rev 1989; 9: 19-35.
11. Herbert JD, Hope DA, Bellack AS.Validity of the distinction between generalized social phobia and avoidant personality disorder. J Abnorm Psychol 1992; 101: 332-9.
12. Judd LL. Social phobia: a clinical overview. J Clin Psychiatry 1994; 55: 5-9.
13. Magee WJ, Eaton WW, Wittchen HU, McGonagle KA, Kessler RC. Agoraphobia, simple phobia, and social phobia in the National Comorbidity Survey. Arch Gen Psychiatry 1996; 53: 159-68.
14. Faravelli C, Abrardi L, Bartolozzi D, Cecchi C, Cosci F, D'Adamo D, et al. The Sesto Fiorentino study: point and oneyear prevalences of psychiatric disorders in an Italian community sample using clinical interviewers. Psychother Psychosom 2004; 73: 226-34. (Pubitemid 38822723)
15. Schneier FR, Johnson J, Hornig CD, Liebowitz MR,Weissman MM. Social phobia. Comorbidity and morbidity in an epidemiological sample.Arch Gen Psychiatry 1992; 49: 282-8.
16. Turner SM, Beidel DC, Townsley RM. Social phobia: a comparison of specific and generalized subtypes and avoidant personality disorder. J Abnorm Psychol 1992; 101: 326-31.
17. Gokalp PG,Tukel R, Solmaz D,Demir T,Kiziltan E,Demir D, et al. Clinical features and co-morbidity of social phobics inTurkey. Eur Psychiatr 2001; 16: 115-21.
18. Grant BF, Hasin DS, Blanco C, Stinson FS, Chou SP, Goldstein RB, et al.The epidemiology of social anxiety disorder in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 2005; 66: 1351-61. (Pubitemid 41779531)
19. Lampe L, Slade T, Issakidis C,Andrews G. Social phobia in the Australian National Survey of Mental Health and Well-Being (NSMHWB). Psych Med 2003; 33: 637-46. (Pubitemid 36626045)
20. Kessler RC, Stang P, Wittchen HU, Stein M, Walters EE. Lifetime co-morbidities between social phobia and mood disorders in the US National Comorbidity Survey. Psych Med 1999; 29: 555-67. (Pubitemid 29261344)
21. Potts NL, Davidson JR, Krishnan KR, Doraiswamy PM. Magnetic resonance imaging in social phobia. Psychiatry Res 1994; 52: 35-42. (Pubitemid 24158102)
22. Davidson JR, Krishnan KR, Charles HC, Boyko O, Potts NL, Ford SM, et al. Magnetic resonance spectroscopy in social phobia: preliminary findings. J Clin Psychiatry 1993; 54: 19-25. (Pubitemid 24057370)
23. Tupler LA, Davidson JR, Smith RD, Lazeyras F, Charles HC, Krishnan KR. A repeat proton magnetic resonance spectroscopy study in social phobia. Biol Psychiatry 1997; 42: 419-24.
24. Schneier FR, Liebowitz MR, Abi-Dargham A, Zea-Ponce Y, Lin SH, Laruelle M. Low dopamine D(2) receptor binding potential in social phobia.Am J Psychiatry 2000; 157: 457-9.
25. Sareen J, Campbell DW, Leslie WD, Malisza KL, Stein MB, Paulus MP, et al. Striatal function in generalized social phobia: a functional magnetic resonance imaging study. Biol Psychiatry 2007; 61: 396-404.
26. Birbaumer N, Grodd W, Diedrich O, Klose U, Erb M, Lotze M, et al. fMRI reveals amygdala activation to human faces in social phobics. Neuroreport 1998; 9: 1223-6.
27. Schneider F, Weiss U, Kessler C, Muller-Gartner HW, Posse S, Sallourn JB, et al. Subcortical correlates of differential classical conditioning of aversive emotional reactions in social phobia. Biol Psychiatry 1999; 45: 863-71.
28. Tillfors M, Furmark T, Marteinsdottir I, Fischer H, Pissiota A, Langstrom B, et al. Cerebral blood flow in subjects with social phobia during stressful speaking tasks: a PET study. Am J Psychiatry 2001; 158: 1220-6.
29. Stein MB, Goldin PR, Sareen J, Zorrilla LT, Brown GG. Increased amygdala activation to angry and contemptuous faces in generalized social phobia.Arch Gen Psychiatry 2002; 59: 1027-34.
30. Veit R, Flor H, Erb M, Hermann C, Lotze M, Grodd W, et al. Brain circuits involved in emotional learning in antisocial behavior and social phobia in humans. Neurosci Lett 2002; 328: 233-6.
31. Lorberbaum JP, Kose S, Johnson MR,Arana GW, Sullivan LK, Hammer MB, et al. Neural correlates of speech anticipatory anxiety in generalized social phobia. Neuroreport 2004; 15: 2701-5.
32. Straube T, Kolassa IT, Glauer M, Mentzel HJ, Miltner WH. Effect of task conditions on brain responses to threatening faces in social phobics: an event-related functional magnetic resonance imaging study. Biol Psychiatry 2004; 56: 921-30.
33. Van Ameringen M, Mancini C, Szechtman H, Nahmias C, Oakman JM,Hall GB, et al.A PET provocation study of generalized social phobia. Psychiatry Res 2004; 132: 13-8.
34. Amir N,Klumpp H,Elias J,Bedwell JS,Yanasak N,Miller LS. Increased activation of the anterior cingulate cortex during processing of disgust faces in individuals with social phobia. Biol Psychiatry 2005; 57: 975-81.
35. Straube T, Mentzel HJ, Miltner WH. Common and distinct brain activation to threat and safety signals insocial phobia. Neuropsychobiology 2005; 52: 163-8.
36. Cooney RE,Atlas LY, Joormann J, Eugene F, Gotlib IH.Amygdala activation in the processing of neutral faces in social anxiety disorder: is neutral really neutral? Psychiatry Res 2006; 148: 55-9.
37. Kilts CD,Kelsey JE,Knight B, Ely TD, Bowman FD,Grodd RE, et al. The neural correlates of social anxiety disorder and response to pharmacotherapy. Neuropsychopharmacology 2006; 31: 2243-53.
38. Phan KL, Fitzgerald DA, Nathan PJ, Tancer ME. Association between amygdala hyperactivity to harsh faces and severity of social anxiety in generalized social phobia. Biol Psychiatry 2006; 59: 424-9.
39. Yoon KL, Fitzgerald DA, Angstadt M, McCarron RA, Phan KL. Amygdala reactivity to emotional faces at high and low intensity in generalized social phobia: a 4-Tesla functional MRI study. Psychiatry Res 2007; 154: 93-8.
40. Evans KC, Wright CI, Wedig MM, Gold AL, Pollack MH, Rauch SL. A functional MRI study of amygdala responses to angry schematic faces in social anxiety disorder. Depress Anxiety 2008; 25: 496-505.
41. Gentili C, Gobbini MI, Ricciardi E, Vanello N, Pietrini P, Harby JV, et al. Differential modulation of neural activity throughout the distributed neural system for face perception in patients with social phobia and healthy subjects. Brain Res Bull 2008. Epub ahead of print.
42. Quadflieg S, Mohr A, Mentzel HJ, Miltner WH, Straube T. Modulation of the neural network involved in the processing of anger prosody: the role of task-relevance and social phobia. Biol Psychology 2008; 78: 129-37.
43. Ahs F, Sollers JJ 3rd, Furmark T, Fredrikson M,Thayer JF. Highfrequency heart rate variability and cortico-striatal activity inmen and women with social phobia. Neuroimage 2009; 47: 815-20.
44. Haxby JV, Hoffman EA, Gobbini MI. The distributed human neural system for face perception.Trends Cogn Sci 2000; 4: 223-33.
45. Phan KL, Orlichenko A, Boyd E, Angstadt M, Coccaro EF, Liberzon I, et al. Preliminary evidence of white matter abnormality in the uncinate fasciculus in generalized social anxiety disorder. Biol Psychiatry 2009; 66: 691-4.
46. Adolphs R, Tranel D, Damasio H, Damasio A. Impaired recognition of emotion in facial expressions following bilateral damage to the human amygdala. Nature 1994; 372: 669-72.
47. Adolphs R,Tranel D, Damasio AR.The human amygdala in social judgment. Nature 1998; 393: 470-4.
48. Furmark T, Tillfors M, Marteinsdottir I, Fischer H, Pissiota A, Langstrom B, et al. Common changes in cerebral blood flow in patients with social phobia treated with citalopram or cognitive-behavioral therapy.Arch Gen Psychiatry 2002; 59: 425-33.
49. Blair K,Geraci M, Devido J, McCaffrey D, Chen G, Vythilingam M, et al. Neural response to selfand other referential praise and criticism in generalized social phobia. Arch Gen Psychiatry 2008; 65: 1176-84.
50. Etkin A, Wager TD. Functional neuroimaging of anxiety: a metaanalysis of emotional processing in PTSD, social anxiety disorder, and specific phobia.Am J Psychiatry 2007; 164: 1476-88.
51. Li D, Chokka P, Tibbo P. Toward an integrative understanding of social phobia. J Psychiatry Neurosci 2001; 26: 190-202.
52. Stein MB, Tancer ME, Uhde TW. Heart rate and plasma norepinephrine responsivity to orthostatic challenge in anxiety disorders. Comparison of patients with panic disorder and social phobia and normal control subjects.Arch Gen Psychiatry 1992; 49; 311-7.
53. Coupland NJ, Bailey JE, Potakar JP. Abnormal cardiovascular responses to standing in panic disorder and social phobia. J Psychopharmacol 1995; 9 (suppl 3):A73.
54. Stein MB, Asmundson GJ, Chartier M. Autonomic responsivity in generalized social phobia. J Affect Disord 1994; 31: 211-21.
55. Levin AP, Saoud JB, Strauman T, Gorman JM, Fyer AJ, Crawford R, et al. Responses of "generalized" and "discrete" social phobics during public speaking. JAnxiety Disord 1993; 7: 207-21.
56. Heimberg RG, Hope DA, Dodge CS, Becker RE. DSM-III-R subtypes of social phobia. Comparison of generalized social phobics and public speaking phobics. J Nerv Ment Dis 1990; 178: 172-9.
57. Hofmann SG, Newman MG, Ehlers A, Roth WT. Psychophysiological differences between subgroups of social phobia. J Abnorm Psychology 1995; 104: 224-31.
58. Papp LA, Gorman JM, Liebowitz MR, Fyer AJ, Cohen B, Klein DF. Epinephrine infusions in patients with social phobia. Am J Psychiatry 1988; 145: 733-6.
59. Gorman JM, Fyer MR, Goetz R, Askanazi J, Liebowitz MR, Fyer AJ, et al. Ventilatory physiology of patients with panic disorder. Arch Gen Psychiatry 1988; 45: 31-9.
60. Holt PE, Andrews G. Provocation of panic: three elements of the panic reaction in four anxiety disorders. Behav Res Ther 1989; 27: 253-61.
61. Gorman JM, Papp LA, Martinez J, Goetz RR, Hollander E, Liebowitz MR, et al.High-dose carbon dioxide challenge test in anxiety disorder patients. Biol Psychiatry 1990; 28: 743-57.
62. Caldirola D, Perna G, Arancio C, Bertani A, Bellodi L. The 35% CO2 challenge test in patients with social phobia. Psychiatry Res 1997; 71: 41-8.
63. Liebowitz MR, Fyer AJ, Gorman JM, Dillon D, Davies S, Stein JM, et al. Specificity of lactate infusions in social phobia versus panic disorders.Am J Psychiatry 1985; 142: 947-50.
64. Cowley DS, Arana GW. The diagnostic utility of lactate sensitivity in panic disorder. Arch Gen Psychiatry 1990; 47: 277-84.
65. Uhde T, Terrill DR, Chambless DL. Pentagastrin model of anxiety in humans. Presented at the annual meeting of the American College of Neuropsychopharmacology. Honolulu, Hawaii, 1993.
66. Bradwejn J. CCK oral presentation BAP summer meeting Cambridge. 1997.
67. Bruce M, Scott N, Shine P, Lader M. Anxiogenic effects of caffeine in patients with anxiety disorders. Arch Gen Psychiatry 1992; 49: 867-9.
68. Tancer ME, Stein MB, Uhde TW. Lactic acid response to caffeine in panic disorder: comparison with social phobics and normal controls.Anxiety 1994-1995; 1: 138-40.
69. Nardi AE, Lopes FL, Freire RC, Veras AB, Nascimento I, Valenca AM, et al. Panic disorder and social anxiety disorder subtypes in a caffeine challenge test. Psychiatry Res 2009; 169: 149-53.
70. Coupland NJ, Bell C, Potokar JP, Dorkins E, Nutt DJ. Flumazenil challenge in social phobia. Depress Anxiety 2000; 11: 27-30.
71. Van Ameringen M, Mancini C, Farvolden P, Oakman J. The neurobiology of social phobia: from pharmacotherapy to brain imaging. Curr Psychiatry Rep 2000; 2: 358-66.
72. Mikkelsen EJ, Detlor J, Cohen DJ. School avoidance and social phobia triggered by haloperidol in patients with Tourette's disorder. Am J Psychiatry 1981; 138: 1572-6. (Pubitemid 12242820)
73. Argyropoulos SV, Bell CJ, Nutt DJ. Brain function in social anxiety disorder. Psychiatr Clin North Am 2001; 24: 707-22.
74. Tiihonen J, Kuikka J, Bergstrom K, Lepola U, Koponen H, Leinonen E. Dopamine reuptake site densities in patients with social phobia.Am J Psychiatry 1997; 154: 239-42.
75. Schneier FR, Martinez D, Abi-Dargham A, Zea-Ponce Y, Simpson HB, Liebowitz MR, et al. Striatal dopamine D(2) receptor availability in OCD with and without comorbid social anxiety disorder: preliminary findings. Depress Anxiety 2008; 25: 1-7.
76. Schneier FR, Abi-Dargham A, Martinez D, Slifstein M, Hwang DR, Liebowitz MR, et al. Dopamine transporters, D2 receptors, and dopamine release in generalized social anxiety disorder.Depress Anxiety 2009; 26: 411-8.
77. Stein MB, Delaney SM, Chartier MJ, Kroft CD, Hazen AL. [3H]paroxetine binding to platelets of patients with social phobia: comparison to patients with panic disorder and healthy volunteers. Biol Psychiatry 1995; 37: 224-8.
78. Chatterjee S, Sunitha TA, Velayudhan A, Khanna S. An investigation into the psychobiology of social phobia: personality domains and serotonergic function.Acta Psychiatr Scand 1997; 95: 544-50.
79. Hollander E, Kwon J, Weiller F, Cohen L, Stein DJ, DeCaria C, et al. Serotonergic function in social phobia: comparison to normal control and obsessive-compulsive disorder subjects. Psychiatry Res 1998; 79: 213-7. (Pubitemid 28346469)
80. Tancer ME, Mailman RB, Stein MB, Mason GA, Carson SW, Golden RN. Neuroendocrine responsivity to monoaminergic system probes in generalized social phobia. Anxiety 1994-1995; 1: 216-23.
81. Argyropoulos SV, Hood SD, Adrover M, Bell CJ, Rich AS, Nash JR, et al.Tryptophan depletion reverses the therapeutic effect of selective serotonin reuptake inhibitors in social anxiety disorder. Biol Psychiatry 2004; 56: 503-9. (Pubitemid 39278248)
82. Kalueff A, Nutt DJ. Role of GABA in memory and anxiety.Depress Anxiety 1996-1997; 4: 100-10.
83. Kalueff AV, Nutt DJ. Role of GABA in anxiety and depression. Depress Anxiety 2007; 24: 495-517.
84. Johnson MR, Marazziti D, Brawman-Mintzer O, Emmanuel NP, Ware MR, Morton WA, et al. Abnormal peripheral benzodiazepine receptor density associated with generalized social phobia. Biol Psychiatry 1998; 43: 306-9. (Pubitemid 28085679)
85. Argyropoulos SV, Sandford JJ, Nutt DJ. The psychobiology of anxiolytic drug. Part 2: pharmacological treatments of anxiety. Pharmacol Ther 2000; 88: 213-27.
86. Bell CJ, Malizia AL, Nutt DJ. The neurobiology of social phobia. Eur Arch Psychiatry Clin Neurosci 1999; 249 (suppl 1): S11-8.
87. Malizia AL, Cunningham VJ, Bell CJ, Liddle PF, Jones T, Nutt DJ. Decreased brain GABA(A)-benzodiazepine receptor binding in panic disorder: preliminary results from a quantitative PET study.Arch Gen Psychiatry 1998; 55: 715-20.
88. Barrett LF, Wager TD. The structure of emotion: evidence from neuroimaging studies. Curr Dir Psychol Sci 2006; 15: 79-83.
89. Stein MB, Simmons AN, Feinstein JS, Paulus MP. Increased amygdala and insula activation during emotion processing in anxiety-prone subjects.Am J Psychiatry 2007; 164: 318-27.
90. Watson D. Rethinking the mood and anxiety disorders: a quantitative hierarchical model for DSM-V. J Abnorm Psychology 2005; 114: 522-36. (Pubitemid 41746989)